Dongliang Yan

Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma

Weiwei Shi, Shan Zhang, Ding Ma et al. · Frontiers in Oncology · 2020 · 61 citations · Full text

Medicine, Oncology, Pharmacology +13

SphK2/S1P Promotes Metastasis of Triple-Negative Breast Cancer Through the PAK1/LIMK1/Cofilin1 Signaling Pathway

Weiwei Shi, Ding Ma, Yin Cao et al. · Frontiers in Molecular Biosciences · 2021 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +17

<p>DEP Domain-Containing Protein 1B (DEPDC1B) Promotes Migration and Invasion in Pancreatic Cancer Through the Rac1/PAK1-LIMK1-Cofilin1 Signaling Pathway</p>

Shan Zhang, Weiwei Shi, Wei Hu et al. · OncoTargets and Therapy · 2020 · 31 citations · Full text

Medicine, Molecular Biology, Oncology +16

Single‐cell RNA sequencing identify SDCBP in ACE2‐positive bronchial epithelial cells negatively correlates with COVID‐19 severity

Ding Ma, Shuwen Liu, Lili Hu et al. · Journal of Cellular and Molecular Medicine · 2021 · 28 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome

Dongliang Yan, Kuixiang Liang, Zhonghua Xu · International Urology and Nephrology · 2015 · 20 citations

Medicine, Urology, Pain Medicine +5